Coram Healthcare Corp Institutional Investor Sentiment Increased in Q1 2018

June 14, 2018 - By Winifred Garcia

CRH plc (NYSE:CRH) Logo

Sentiment for Coram Healthcare Corp (NYSE:CRH)

Coram Healthcare Corp (NYSE:CRH) institutional sentiment increased to 1.6 in 2018 Q1. Its up 0.63, from 0.97 in 2017Q4. The ratio is better, as 67 active investment managers increased or started new stock positions, while 42 sold and decreased stock positions in Coram Healthcare Corp. The active investment managers in our partner’s database now own: 36.17 million shares, up from 28.53 million shares in 2017Q4. Also, the number of active investment managers holding Coram Healthcare Corp in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 13 Reduced: 29 Increased: 46 New Position: 21.

CRH plc, through its subsidiaries, manufactures and distributes building materials. The company has market cap of $31.73 billion. The firm operates through seven divisions: Europe Heavyside, Europe Lightside, Europe Distribution, Americas Materials, Americas Products, Americas Distribution, and Asia. It has a 13.68 P/E ratio. The firm makes and supplies cement, aggregates, ready-mixed and precast concrete, concrete landscaping, and asphalt products; and construction accessories, shutters and awnings, and fencing and composite access chambers.

The stock increased 0.69% or $0.26 during the last trading session, reaching $37.92. About 251,426 shares traded. CRH plc (NYSE:CRH) has risen 1.50% since June 14, 2017 and is uptrending. It has underperformed by 11.07% the S&P500.

Cutter & Co Brokerage Inc. holds 1% of its portfolio in CRH plc for 74,540 shares. Renaissance Group Llc owns 497,205 shares or 0.58% of their US portfolio. Moreover, Thomas White International Ltd has 0.56% invested in the company for 99,309 shares. The Georgia-based Gmt Capital Corp has invested 0.46% in the stock. Todd Asset Management Llc, a Kentucky-based fund reported 457,733 shares.

CRH plc (NYSE:CRH) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: